Ibrutinib in the Treatment of Relapsed Chronic Lymphocytic Leukemia
Aim. To estimate ibrutinib efficacy in the treatment of first early CLL relapses and in patients with ≥ 2 lines of preceding therapy. Analysis of treatment results in patients with del(17p) and monitoring of minimal residual disease (MRD) and ibrutinib safety profile. Materials & Methods. The ana...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
Practical Medicine Publishing House
2018-01-01
|
| Schriftenreihe: | Клиническая онкогематология |
| Schlagworte: | |
| Online-Zugang: | https://bloodjournal.ru/index.php/coh/article/view/349 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|